In conclusion, resveratrol can be used as an important biotherapeutic agent that significantly reduces histone and IL-1β-mediated cell damage due to diabetes, supports anti-inflammatory and innate host defense via β-defensin 1, and reduces target organ damage in organs such as liver and kidney. This evidence concerns the gene IL1B and diabetes mellitus.